NEWS

Cromos Pharma and Avance Clinical share details of innovative collaboration at BIO-Europe 2020 Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies.

Orphan Drugs Market to Reach USD 340.84 Billion by 2027

Cromos Pharma and Avance Clinical launch scalable clinical trial solution for biotech

Video: Cromos Pharma and Avance Clinical Collaboration Cromos Pharma and Avance Clinical with operations in Europe and Australia, respectively, are successfully collaborating on a scalable clinical solution for biotechs.  The collaboration allows biotechs to quickly start their pre-IND early phase studies in Australia, then expand to Central/Eastern Europe to access the large patient populations for their Phase 2 and 3 studies. Importantly, the

Alzheimer’s Awareness Month: Q&A with Dr Sabina Brennan September is World Alzheimer’s Month. Alzheimer’s Disease (AD) is the most well-known form of dementia. Dementia is the collective name for progressive brain conditions affecting memory, thinking, behavior and emotions. Dementia affects almost 50 million people worldwide. While aging is a major risk factor for dementia, it also affects people under 65 years.  There are over 100 forms of

Watch Webinar: Where in the world should I locate my pivotal clinical trial?